On November 5, 2015 Health Canada released a product label update for Abilify stating that the label had been updated to advise of an increased risk of impulsive behaviors such as gambling and hypersexuality. There is increasing evidence which suggest side effects of Abilify may lead to: Binge Eating Hypersexual Behavior Compulsive Shopping Compulsive Gambling...
The post Canadian Government Changes Label On Abilify appeared first on McEwen Law Firm.